Endocrine-disrupting chemicals may contribute to obesity and adiposity in humans.

This narrative mini-review synthesizes evidence from human studies investigating the impact of endocrine-disrupting chemicals (EDCs) on metabolic health. The review focuses on conditions related to obesity, including adipogenic differentiation, adiposity, body weight, BMI, and abdominal obesity. No specific medications or controlled interventions were evaluated, as the exposure was to environmental chemicals rather than therapeutic agents.

Main results indicate that adipogenic differentiation is affected by a wide variety of EDCs, though specific effect sizes and absolute numbers were not reported. Similarly, adiposity is associated with chemical exposure, but precise statistical data, p-values, or confidence intervals are not provided in this narrative synthesis. The review notes that the strength and consistency of these effects are still not entirely understood across the available literature.

Safety and tolerability data were not reported for this review. Key limitations include the uncertainty regarding how effects may differ based on the specific EDCs involved, the timing of exposure, and the sex of the individuals. Consequently, the review does not establish definitive causal links but rather reports associations between exposure and adiposity.

The practice relevance of this evidence suggests that public health interventions should prioritize identifying and regulating EDCs. Clinicians should recognize that while EDCs may contribute to adipogenesis and metabolic dysfunction, the current evidence is observational and incomplete. Further research is needed to clarify the mechanisms and variability of these effects before specific clinical recommendations can be made.